Trials / Completed
CompletedNCT03172221
Clinical Performance of the HRP2 HS-RDT for Malaria Diagnosis in Pregnant Women
Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 880 (actual)
- Sponsor
- Foundation for Innovative New Diagnostics, Switzerland · Academic / Other
- Sex
- Female
- Age
- 15 Years
- Healthy volunteers
- —
Summary
This is a cross-sectional and multicentre clinical trial to study the performance of the Histidine Rich Protein 2 (HRP2) highly sensitive rapid diagnostic test (HS-RDT) for the detection of malaria during pregnancy in low transmission settings from Colombia and Indonesia. The new HS-RDT will be compared with conventional good quality RDTs, microscopy, and NAATs \[loop-mediated isothermal amplification (LAMP), nested PCR (nPCR)\], in peripheral blood samples with quantitative reverse transcription PCR (qRT-PCR) as reference standard.
Detailed description
The activities proposed will be performed in the context of health centres receiving pregnant women for antenatal care visit. Finger-prick blood (300 µL) will be collected and used to test for malaria with the HS-RDT, as well as with conventional good quality RDTs, microscopy and local NAATs (LAMP and nPCR). Dried blood spots will also be collected for qRT-PCR testing. Patient information (demographics, obstetric history, malaria prevention measures, etc.) as well as laboratory results will be recorded and entered into a dedicated database.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | HS-RDT | A single finger-prick blood sample will be collected and used to test participants with the HS-RDT. The results of the results of the test will not be used for treatment purposes nor used to inform patient care. |
Timeline
- Start date
- 2017-07-25
- Primary completion
- 2018-01-31
- Completion
- 2018-01-31
- First posted
- 2017-06-01
- Last updated
- 2023-11-30
Locations
2 sites across 1 country: Colombia
Source: ClinicalTrials.gov record NCT03172221. Inclusion in this directory is not an endorsement.